The Safety and Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Yin, Guo-Qiang; Li, Zu-Lei; Li, Dong

Yin, Guo-Qiang; Li, Zu-Lei; Li, Dong.

Afiliación

Yin GQ; Department of Thoracic Surgery, Zibo Central Hospital, Zibo, Shandong Province, 255000, People's Republic of China.
Li ZL; Department of Thoracic Surgery, Zibo Central Hospital, Zibo, Shandong Province, 255000, People's Republic of China.
Li D; Department of Thoracic Surgery, Zibo Central Hospital, Zibo, Shandong Province, 255000, People's Republic of China.

Cancer Manag Res ; 14: 2133-2141, 2022.

Article en En | MEDLINE | ID: mdl-35795828

Palabras clave

camrelizumab; chemotherapy; esophageal squamous cell carcinoma; neoadjuvant therapy; survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Cancer Manag Res Año: 2022 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google